New pricing for public sector healthcare providers in Finland
We have updated the pricing for our Parkinson’s disease measurement and analysis service for public sector healthcare providers in Finland. The new pricing model improves access to objective symptom monitoring for healthcare organizations seeking to optimize Parkinson’s disease care.
The Adamant Health measurement and analysis service complements clinical assessment and helps clinicians gain a more holistic view of a patient’s condition by collecting symptom data over an extended period and at home.
Using a wearable device that combines surface electromyography (EMG) and kinematic measurements, we add the measurement of neuromuscular signals to motion measurement for deeper insight into a patient’s muscle activity. By cross-validating findings across the two technologies, EMG and kinematic measurements, the service delivers objective data on patients’ motor symptoms and provides more meaningful and holistic clinical insight to support therapeutic decision-making and treatment planning.
“By bringing objective symptom data into routine clinical practice, healthcare providers gain a more comprehensive understanding of a patient’s symptom severity and fluctuations and can create highly personalized treatment plans for optimal symptom control – improving a patient’s care balance over time,” says Anne Räsänen, Director, Business Development at Adamant Health. “Through continuous innovation and technological advancement, we are making objective symptom monitoring more accessible to public sector healthcare providers in Finland.”
Interested in learning more?
Contact us to get a quote and to discuss how we can support Parkinson’s disease care in your organization:
Anne Räsänen
Director, Business Development
Mobile: +358 44 733 8579
anne.rasanen@adamanthealth.com